Lotus Eye Hospital and Institute Limited

For FY26 (year ended 31 Mar 2026), Lotus Eye Hospital and Institute Limited reported revenue of Rs 53.7 Cr and net profit of Rs 0.1 Cr, with a net margin of 0.15% and earnings per share of Rs 0.04 (standalone statements).

Year-on-year change: revenue +7.92%; net profit −89.12%; EPS −88.89%. Three-year compound annual growth rate: revenue +4.43%; net profit −72.98%.

At the same date the balance sheet shows total assets of Rs 82.6 Cr, shareholders' equity of Rs 60.1 Cr, total debt of Rs 11.4 Cr, cash of Rs 1.8 Cr, a debt-to-equity ratio of 0.19 and operating cash flow of Rs 3.1 Cr.

On a trailing-twelve-month basis the filings add up to revenue of Rs 57.3 Cr, net income of Rs 0.1 Cr and a net margin of 0.26%.

In the shareholding pattern for 30 Sept 2026, Lotus Eye Hospital and Institute Limited's ownership is split: promoters 40.14%; domestic institutional investors (DIIs) 0.02%; retail and other shareholders 59.86%.

Compared with the filing for 30 Jun 2026: promoter holding 0.00 percentage points; DII holding 0.00 percentage points.

The same filing lists reported promoter pledge of 87.15% and 9,572 shareholders on record.

46 BSE corporate announcements were filed by Lotus Eye Hospital and Institute Limited in the past twelve months; the most frequent category is "Company Update" (22). The most recent is "Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018" (Company Update), filed on 8 Oct 2026.

The disclosed corporate-action timeline lists 2 entries: dividend (2). The latest is a dividend (Final Dividend - Rs. - 0.5000) with ex-date 18 Sept 2023.